Evaxion - Cash Flow from Financial Activities 2020-2025 | EVAX
Evaxion - cash flow from financial activities from 2020 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| Evaxion - Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $13 |
| 2023 | $11 |
| 2022 | $8 |
| 2021 | $50 |
| 2020 | $9 |
| 2019 | $10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.003B |
| Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.328B | 59.20 |
| Hims & Hers Health (HIMS) | United States | $12.250B | 127.28 |
| Tempus AI (TEM) | United States | $10.726B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.629B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.081B | 63.76 |
| Hinge Health (HNGE) | United States | $3.147B | 0.00 |
| Privia Health (PRVA) | United States | $2.800B | 191.42 |
| Enovis (ENOV) | United States | $1.753B | 9.77 |
| Schrodinger (SDGR) | United States | $1.680B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 25.64 |
| Azenta (AZTA) | United States | $1.298B | 60.34 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.644B | 0.00 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.584B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 170.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 793.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.50 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |